331 related articles for article (PubMed ID: 26380984)
1. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.
Guo SM; Han M; Chen MX; Ning Y; Pei GC; Li YQ; Dai W; Ge SW; Deng YJ; Guo YY; Li XQ; Haller H; Xu G; Rong S
PLoS One; 2015; 10(9):e0138718. PubMed ID: 26380984
[TBL] [Abstract][Full Text] [Related]
2. Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy.
Zhao Y; Liu L; Huang J; Shi S; Lv J; Liu G; Zhao M; Zhang H
PLoS One; 2015; 10(7):e0132869. PubMed ID: 26167688
[TBL] [Abstract][Full Text] [Related]
3. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Salcedo MT
Nefrologia; 2014; 34(1):53-61. PubMed ID: 24463863
[TBL] [Abstract][Full Text] [Related]
4. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
Jin J; Li YW; He Q
Transplant Proc; 2015; 47(6):1760-5. PubMed ID: 26293047
[TBL] [Abstract][Full Text] [Related]
5. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
Spinale JM; Mariani LH; Kapoor S; Zhang J; Weyant R; Song PX; Wong HN; Troost JP; Gadegbeku CA; Gipson DS; Kretzler M; Nihalani D; Holzman LB;
Kidney Int; 2015 Mar; 87(3):564-74. PubMed ID: 25354239
[TBL] [Abstract][Full Text] [Related]
6. The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis.
Meijers B; Maas RJ; Sprangers B; Claes K; Poesen R; Bammens B; Naesens M; Deegens JK; Dietrich R; Storr M; Wetzels JF; Evenepoel P; Kuypers D
Kidney Int; 2014 Mar; 85(3):636-40. PubMed ID: 24402090
[TBL] [Abstract][Full Text] [Related]
7. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Chen Y; Zhao MH
Kidney Int; 2013 Aug; 84(2):366-72. PubMed ID: 23447064
[TBL] [Abstract][Full Text] [Related]
8. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
[TBL] [Abstract][Full Text] [Related]
9. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
BMC Med; 2014 May; 12():81. PubMed ID: 24884842
[TBL] [Abstract][Full Text] [Related]
10. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children.
Sinha A; Bajpai J; Saini S; Bhatia D; Gupta A; Puraswani M; Dinda AK; Agarwal SK; Sopory S; Pandey RM; Hari P; Bagga A
Kidney Int; 2014 Mar; 85(3):649-58. PubMed ID: 24429405
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.
Winnicki W; Sunder-Plassmann G; Sengölge G; Handisurya A; Herkner H; Kornauth C; Bielesz B; Wagner L; Kikić Ž; Pajenda S; Reiter T; Schairer B; Schmidt A
Sci Rep; 2019 Sep; 9(1):13783. PubMed ID: 31551522
[TBL] [Abstract][Full Text] [Related]
12. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
13. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease.
Wada T; Nangaku M; Maruyama S; Imai E; Shoji K; Kato S; Endo T; Muso E; Kamata K; Yokoyama H; Fujimoto K; Obata Y; Nishino T; Kato H; Uchida S; Sasatomi Y; Saito T; Matsuo S
Kidney Int; 2014 Mar; 85(3):641-8. PubMed ID: 24429394
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of soluble urokinase-type plasminogen activator receptor serum levels in adults with idiopathic nephrotic syndrome].
Segarra A; Jatem E; Quiles MT; Arbós MA; Ostos H; Valtierra N; Carnicer C; Agraz I; Salcedo MT
Nefrologia; 2014; 34(1):46-52. PubMed ID: 24463862
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis.
Shuai T; Pei Jing Y; Huang Q; Xiong H; Liu J; Zhu L; Yang K; Jian L
BMJ Open; 2019 Oct; 9(10):e031812. PubMed ID: 31594897
[TBL] [Abstract][Full Text] [Related]
16. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
[TBL] [Abstract][Full Text] [Related]
17. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
Franco Palacios CR; Lieske JC; Wadei HM; Rule AD; Fervenza FC; Voskoboev N; Garovic VD; Zand L; Stegall MD; Cosio FG; Amer H
Transplantation; 2013 Aug; 96(4):394-9. PubMed ID: 23736353
[TBL] [Abstract][Full Text] [Related]
18. Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis.
Harita Y; Ishizuka K; Tanego A; Sugawara N; Chikamoto H; Akioka Y; Tsurumi H; Miura K; Gotoh Y; Tsujita M; Yamamoto T; Horike K; Takeda A; Oka A; Igarashi T; Hattori M
Pediatr Nephrol; 2014 Sep; 29(9):1553-60. PubMed ID: 24705794
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases.
Haas M
Am J Kidney Dis; 1996 Sep; 28(3):365-71. PubMed ID: 8804234
[TBL] [Abstract][Full Text] [Related]
20. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
